What do you monitor?
Curated feeds for your role. Pick your area and get exactly the sources you need.
Compliance & Legal
Legal Research
Court opinions, regulatory guidance, and enforcement actions. AI-summarized.
Financial Compliance
SEC, OCC, FDIC, Fed, FINRA, CFPB, FASB, and state banking regulators. One feed.
Insurance Compliance
State commissioner bulletins, NAIC model laws, and DOI enforcement actions.
Environmental Compliance
EPA enforcement, state environmental agencies, PFAS regulatory updates.
Data Privacy
State AG privacy enforcement, FTC actions, CPPA rulemaking, and HIPAA enforcement.
Tax Compliance
IRS guidance changes and state tax department bulletins.
AML Compliance
FinCEN, OCC, FDIC, Fed, FATF, and banking regulator enforcement.
Labor & Employment
NLRB decisions, EEOC guidance, DOL wage updates, and 50-state labor law changes.
Immigration Law
USCIS policy changes, visa bulletin updates, CBP processing changes.
Industry
Pharma & Life Sciences
FDA warning letters, drug approvals, ICH guidelines, EMA updates, and DEA scheduling.
Energy & Utilities
FERC orders, state PUC decisions, and energy regulatory changes.
Cybersecurity
CISA KEV catalog, ICS-CERT, NSA advisories, NIST CSF, and FedRAMP updates.
Healthcare Compliance
CMS transmittals, OIG work plan, HIPAA enforcement, and Medicaid updates.
Trade & Procurement
Recent changes
Ninth Circuit Reverses FCA Case Against AbbVie for 340B Pricing Fraud
The Ninth Circuit reversed the district court in United States ex rel. Adventist Health System of West v. AbbVie Inc., holding that the False Claims Act provides an independent mechanism for relators to pursue claims alleging fraudulent drug pricing in violation of the 340B Program, even though Section 340B itself contains no private right of action. The court rejected manufacturers' arguments that FCA claims require a prior HRSA violation. The ruling exposes pharmaceutical manufacturers to significant FCA liability for 340B pricing practices.
FDA Updates Patient Preference Information Guidance for Medical Devices
FDA's Center for Devices and Radiological Health and Center for Biologics Evaluation and Research issued final guidance on Incorporating Voluntary Patient Preference Information over the Total Product Life Cycle, superseding the August 2016 guidance. The 2026 guidance clarifies scope across the device lifecycle and substantially enhances methodological specificity for PPI studies. The guidance now expressly recognizes PPI relevance to 510(k) submissions and postmarket enforcement decisions.
Colorado Conversion Therapy Ban Unconstitutional - First Amendment
The Supreme Court ruled 8-1 in Chiles v. Salazar that Colorado's 2019 law prohibiting licensed mental health counselors from performing conversion therapy on minors is unconstitutional. The Court held the statute violated a counselor's First Amendment rights by directly regulating the content and viewpoint of speech during counseling sessions. Colorado's argument that the law regulated professional conduct with only incidental speech effects was rejected.
FPI Debt Investment Limits and Credit Default Swaps
The Reserve Bank of India has issued A.P. (DIR Series) Circular No. 05 setting FPI investment limits for FY 2026-27 (April 2026 to March 2027). The percentage limits for G-Secs (6%), SGSs (2%), and corporate bonds (15%) of outstanding stocks remain unchanged under the General Route. A key policy change requires all Voluntary Retention Route investments to now be subject to General Route limits. Total debt limits have been revised to ₹15,51,646 crore for the first half and ₹16,32,640 crore for the second half, with an additional ₹3,30,464 crore CDS limit.
CONNECT THE DOTS - Trademark Opposition
Tootsie Roll Industries, LLC filed a trademark opposition against DPGC Group LLC regarding the mark 'CONNECT THE DOTS' with the USPTO Trademark Trial and Appeal Board. A motion to suspend proceedings with consent is pending while settlement negotiations continue. The opposition proceeding is TTAB91299872.
DR. SITI Trademark Opposition - Doctor Siti Inc. vs Xianglong Meng
USPTO TTAB Opposition No. TTAB91300879 involving the DR. SITI trademark between Plaintiff Doctor Siti Inc. and Defendant Xianglong Meng. Plaintiff filed a motion to suspend proceedings with consent pending settlement negotiations. The opposition, filed August 7, 2025, remains ongoing as parties pursue settlement.
NORTEL trademark cancellation denied
The USPTO Trademark Trial and Appeal Board denied Cancellation No. 92090198, filed by 2371436 Ontario Inc. against Nortel Networks Limited regarding the NORTEL trademark. The Board issued a final decision denying the cancellation without prejudice on April 3, 2026. The petition was filed on November 23, 2025.
Officer-Involved Shooting Investigation in Raymond NH
The New Hampshire Attorney General's Office released findings from the autopsy of Matthew J. Masse, age 38, determining his cause of death was a self-inflicted gunshot wound to the chin/head with manner of death ruled suicide. The investigation into the officer-involved use of deadly force remains ongoing, with the identity of officers involved pending completion of formal interviews in the coming weeks.
Free Scam Prevention Training for Older Adults
The New Hampshire Attorney General's Office announced free scam prevention training sessions for older adults during Financial Literacy Month in April 2026. Three community presentations will be held in Rochester and Manchester, covering impostor scams, payment methods used by fraudsters, identity fraud, and reporting procedures. Sessions are open to older adults, caregivers, family members, and community members with no enrollment required.
Idaho Power 2032 All-Source RFP Approval
The Idaho Public Utilities Commission issued a Notice of Parties establishing the procedural participants in Case No. IPC-E-26-03, involving Idaho Power Company's application for approval of its 2032 All-Source Request for Proposals. The notice identifies Idaho Power, Commission Staff, IIPA, NIPPC, Boise City, and Micron as parties, and specifies service requirements per IDAPA 31.01.01 rules.
Browse by country
United States
1815 sources
United Kingdom
90 sources
European Union
77 sources
Canada
39 sources
International
39 sources
Australia
22 sources
Singapore
21 sources
India
13 sources
France
13 sources
Japan
10 sources
Italy
8 sources
Hong Kong
7 sources
Switzerland
6 sources
Ireland
6 sources
Germany
6 sources
Poland
5 sources
MT
5 sources
UAE
4 sources
New Zealand
4 sources
Luxembourg
4 sources
South Africa
3 sources
NG
3 sources
South Korea
3 sources
GH
3 sources
CL
2 sources
GG
2 sources
GI
2 sources
SA
2 sources
Austria
2 sources
KY
2 sources
CY
2 sources
KE
2 sources
Norway
2 sources
Netherlands
2 sources
IL
1 sources
Greece
1 sources
INT
1 sources
LK
1 sources
SE
1 sources
Hungary
1 sources
Romania
1 sources
Uganda
1 sources
Spain
1 sources
Croatia
1 sources
CO
1 sources
Finland
1 sources
BM
1 sources
MU
1 sources
QA
1 sources
DK
1 sources
Browse by category
Courts & Legal
362 sources
Banking & Finance
292 sources
Government & Legislation
280 sources
Trade & Sanctions
136 sources
Healthcare
136 sources
Labor & Employment
113 sources
Securities & Markets
104 sources
Pharma & Drug Safety
104 sources
Energy
101 sources
Environment
86 sources
Data Privacy & Cybersecurity
74 sources
Tax
66 sources
Agriculture & Food Safety
64 sources
Insurance
58 sources
Transportation
57 sources
Defense & National Security
52 sources
Telecom & Technology
47 sources
Consumer Protection
44 sources
Education
19 sources
Housing
16 sources
Securities Regulation
9 sources
Environmental Regulation
8 sources
Immigration
8 sources
Public Health
3 sources
AI Regulation
3 sources
Financial Regulation
2 sources
Browse by agency
Get alerts when regulations change
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.